Gregory Conn, Ph.D.

Gregory Conn, Ph.D.

Chief Scientific OfficeratPDS Biotechnology· In proxies 2022–2023

Pay in FY2023PDS Biotechnology stock -62.3% the same year

Gregory Conn, Ph.D. was paid $1.7M in FY2023 (Dec). PDS Biotechnology stock fell 62.3% that year.

Pay$100 in the stock at the end of FY22 → $38
Pay is from the Summary Compensation Table of each PDS Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PDS BiotechnologyPublic company · 4 yr
    • Chief Scientific Officer2022 – Present · 4 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?